171 related articles for article (PubMed ID: 29397737)
1. Label-Free Confocal Raman Mapping of Transportan in Melanoma Cells.
Cosme PJ; Ye J; Sears S; Wojcikiewicz EP; Terentis AC
Mol Pharm; 2018 Mar; 15(3):851-860. PubMed ID: 29397737
[TBL] [Abstract][Full Text] [Related]
2. Protein and siRNA delivery by transportan and transportan 10 into colorectal cancer cell lines.
Wierzbicki PM; Kogut-Wierzbicka M; Ruczynski J; Siedlecka-Kroplewska K; Kaszubowska L; Rybarczyk A; Alenowicz M; Rekowski P; Kmiec Z
Folia Histochem Cytobiol; 2014; 52(4):270-80. PubMed ID: 25511292
[TBL] [Abstract][Full Text] [Related]
3. Transportan-derived cell-penetrating peptide delivers siRNA to inhibit replication of influenza virus in vivo.
Zhang C; Ren W; Liu Q; Tan Z; Li J; Tong C
Drug Des Devel Ther; 2019; 13():1059-1068. PubMed ID: 31040643
[TBL] [Abstract][Full Text] [Related]
4. Passage of cell-penetrating peptides across a human epithelial cell layer in vitro.
Lindgren ME; Hällbrink MM; Elmquist AM; Langel U
Biochem J; 2004 Jan; 377(Pt 1):69-76. PubMed ID: 12968950
[TBL] [Abstract][Full Text] [Related]
5. Identification of cell-penetrating peptides that are bactericidal to Neisseria meningitidis and prevent inflammatory responses upon infection.
Eriksson OS; Geörg M; Sjölinder H; Sillard R; Lindberg S; Langel U; Jonsson AB
Antimicrob Agents Chemother; 2013 Aug; 57(8):3704-12. PubMed ID: 23689723
[TBL] [Abstract][Full Text] [Related]
6. Cargo delivery kinetics of cell-penetrating peptides.
Hällbrink M; Florén A; Elmquist A; Pooga M; Bartfai T; Langel U
Biochim Biophys Acta; 2001 Dec; 1515(2):101-9. PubMed ID: 11718666
[TBL] [Abstract][Full Text] [Related]
7. Translocation properties of novel cell penetrating transportan and penetratin analogues.
Lindgren M; Gallet X; Soomets U; Hällbrink M; Bråkenhielm E; Pooga M; Brasseur R; Langel U
Bioconjug Chem; 2000; 11(5):619-26. PubMed ID: 10995204
[TBL] [Abstract][Full Text] [Related]
8. Chimeras of Cell-Penetrating Peptides Demonstrate Synergistic Improvement in Antisense Efficacy.
Fadzen CM; Holden RL; Wolfe JM; Choo ZN; Schissel CK; Yao M; Hanson GJ; Pentelute BL
Biochemistry; 2019 Sep; 58(38):3980-3989. PubMed ID: 31450889
[TBL] [Abstract][Full Text] [Related]
9. Blood pressure modulation following activation of mast cells by cationic cell penetrating peptides.
Basheer M; Schwalb H; Shefler I; Levdansky L; Mekori YA; Gorodetsky R
Peptides; 2011 Dec; 32(12):2444-51. PubMed ID: 21971370
[TBL] [Abstract][Full Text] [Related]
10. Cholesterol prevents interaction of the cell-penetrating peptide transportan with model lipid membranes.
Arsov Z; Nemec M; Schara M; Johansson H; Langel U; Zorko M
J Pept Sci; 2008 Dec; 14(12):1303-8. PubMed ID: 18683276
[TBL] [Abstract][Full Text] [Related]
11. Glycosaminoglycans are required for translocation of amphipathic cell-penetrating peptides across membranes.
Pae J; Liivamägi L; Lubenets D; Arukuusk P; Langel Ü; Pooga M
Biochim Biophys Acta; 2016 Aug; 1858(8):1860-7. PubMed ID: 27117133
[TBL] [Abstract][Full Text] [Related]
12. Peptide detection and structure determination in live cells using confocal Raman microscopy.
Terentis AC; Ye J
Methods Mol Biol; 2013; 1081():211-36. PubMed ID: 24014442
[TBL] [Abstract][Full Text] [Related]
13. Transportan in nanocarriers improves skin localization and antitumor activity of paclitaxel.
Pepe D; Carvalho VF; McCall M; de Lemos DP; Lopes LB
Int J Nanomedicine; 2016; 11():2009-19. PubMed ID: 27274232
[TBL] [Abstract][Full Text] [Related]
14. Cell transduction pathways of transportans.
Padari K; Säälik P; Hansen M; Koppel K; Raid R; Langel U; Pooga M
Bioconjug Chem; 2005; 16(6):1399-410. PubMed ID: 16287236
[TBL] [Abstract][Full Text] [Related]
15. Interaction and structure induction of cell-penetrating peptides in the presence of phospholipid vesicles.
Magzoub M; Kilk K; Eriksson LE; Langel U; Gräslund A
Biochim Biophys Acta; 2001 May; 1512(1):77-89. PubMed ID: 11334626
[TBL] [Abstract][Full Text] [Related]
16. Cell penetrating peptides fail to induce an innate immune response in epithelial cells in vitro: implications for continued therapeutic use.
Carter E; Lau CY; Tosh D; Ward SG; Mrsny RJ
Eur J Pharm Biopharm; 2013 Sep; 85(1):12-9. PubMed ID: 23958314
[TBL] [Abstract][Full Text] [Related]
17. Determination of penetratin secondary structure in live cells with Raman microscopy.
Ye J; Fox SA; Cudic M; Rezler EM; Lauer JL; Fields GB; Terentis AC
J Am Chem Soc; 2010 Jan; 132(3):980-8. PubMed ID: 20041639
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of cell-penetrating peptides (CPPs) as vehicles for intracellular delivery of antisense peptide nucleic acid (PNA).
Bendifallah N; Rasmussen FW; Zachar V; Ebbesen P; Nielsen PE; Koppelhus U
Bioconjug Chem; 2006; 17(3):750-8. PubMed ID: 16704214
[TBL] [Abstract][Full Text] [Related]
19. Co-administration of Transportan Peptide Enhances the Cellular Entry of Liposomes in the Bystander Manner Both In Vitro and In Vivo.
Li YX; Wang N; Hasan MM; Pang HB
Mol Pharm; 2022 Nov; 19(11):4123-4134. PubMed ID: 36070496
[TBL] [Abstract][Full Text] [Related]
20. Cellular uptake of cell-penetrating peptides pVEC and transportan in plants.
Chugh A; Eudes F
J Pept Sci; 2008 Apr; 14(4):477-81. PubMed ID: 17985395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
